Showing a limited preview of this publication:
Abstract
In this comprehensive review, we summarize the current state-of-the-art of neurochemical biomarkers for Alzheimer's disease. Predominantly, these biomarkers comprise cerebrospinal fluid biomarkers directly related to the pathophysiology of this disorder (such as amyloid β protein, tau protein). We particularly pay attention to the innovations in this area that have been made in technological aspects during the past 5 years (e.g., multiplex analysis of biomarkers, proteomics), to the discovery of novel, potential biomarkers (e.g., amyloid β oligomers, isoprostanes), and to the extension of this research towards identification of biomarkers in plasma.
Clin Chem Lab Med 2007;45:1421–34.
Keywords: Alzheimer's disease; amyloid β protein; biological markers; cerebrospinal fluid; tau proteins
Received: 2007-6-7
Accepted: 2007-8-28
Published Online: 2007-11-01
Published in Print: 2007-11-01
©2007 by Walter de Gruyter Berlin New York
